EBI (US) goes it alone after Orthofix (Italy) agreement ends
This article was originally published in Clinica
Biomet's EBI subsidiary (US) will develop its own advanced fixation system following the ending of an agreement with its supplier, Orthofix (Italy). The deal expires at the end of May 1995. Orthofix is to acquire American Medical Electronics and gain its US sales force (see Clinica No 654, p 12) for $79 million, a company in which Biomet owns 6% of outstanding shares.
You may also be interested in...
Nina Daily, chief marketing officer at the Professional Beauty Association since July 2018, will succeed Steve Sleeper as executive director at the end of June when Sleeper retires. More cosmetics industry appointments.
Third round of orders would give the US all the vaccine it needs from the existing mRNA products, taking pressure off AstraZeneca is it experiences manufacturing challenges and the EU considers export restrictions to ensure it gets enough vaccine.
Listerine mouthwash drove J&J’s oral care sales up 11.4% in the fourth quarter. Tylenol for adults was the star of its OTC drug business but weakness of children’s Tylenol products and other OTCs led to flat sales.